DI IOIA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.501
EU - Europa 1.230
AS - Asia 673
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
AF - Africa 2
Totale 3.418
Nazione #
US - Stati Uniti d'America 1.495
CN - Cina 315
IE - Irlanda 225
IT - Italia 196
UA - Ucraina 179
TR - Turchia 149
GB - Regno Unito 148
SG - Singapore 141
SE - Svezia 138
DE - Germania 110
FR - Francia 90
FI - Finlandia 65
IN - India 49
RU - Federazione Russa 30
CZ - Repubblica Ceca 17
BE - Belgio 12
EU - Europa 7
CA - Canada 6
CH - Svizzera 6
VN - Vietnam 6
AU - Australia 5
IR - Iran 4
DK - Danimarca 2
GR - Grecia 2
KR - Corea 2
PL - Polonia 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.418
Città #
Chandler 288
Jacksonville 251
Dublin 222
Singapore 120
Southend 116
Princeton 94
Nanjing 85
Ashburn 81
Ann Arbor 76
Izmir 73
Beijing 69
Chieti 67
Dearborn 62
Wilmington 40
Cambridge 39
New York 34
Altamura 32
Santa Clara 30
Nanchang 29
Helsinki 28
Munich 27
Boardman 21
Washington 18
Woodbridge 18
Los Angeles 17
Grevenbroich 15
Brno 14
Kunming 14
Shenyang 13
Brussels 12
Guangzhou 12
Jiaxing 12
Hebei 11
Norwalk 11
Tianjin 11
Hangzhou 9
San Mateo 8
Changsha 7
Frankfurt am Main 7
Houston 7
Monmouth Junction 7
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
London 6
Pescara 5
Roseto Degli Abruzzi 5
Changchun 4
Edinburgh 4
Hanover 4
Montesilvano Marina 4
San Vito Chietino 4
Seattle 4
Teramo 4
Zhengzhou 4
Ardabil 3
Augusta 3
La Spezia 3
Milan 3
Mumbai 3
Ningbo 3
Olomouc 3
Taizhou 3
Tatura 3
Torino 3
Toronto 3
Belgrade 2
Benevento 2
Campodipietra 2
Copenhagen 2
Fairfield 2
Kraków 2
L'aquila 2
Leawood 2
Padova 2
Pianella 2
Redmond 2
Redwood City 2
Tappahannock 2
Verona 2
Amman 1
Andover 1
Anzio 1
Arlington 1
Atlanta 1
Auburn Hills 1
Bangalore 1
Boston 1
Brisbane 1
Cairo 1
Campobasso 1
Candiolo 1
Centrale 1
Chengdu 1
Düsseldorf 1
Edmonton 1
Espoo 1
Genova 1
Totale 2.264
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 177
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 141
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 126
Cleavage of cystatin C is not associated with multiple sclerosis 108
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 106
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 103
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 100
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 100
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 98
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 94
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 91
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 88
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 88
Increasing age at disability milestones among MS patients in the MSBase Registry 86
Data of safety in a single-center alemtuzumab treated population 82
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 81
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 79
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 78
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 75
Nail loss after teriflunomide treatment: a new potential adverse event 74
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 73
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 73
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 73
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 71
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 70
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 69
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 69
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 68
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 66
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 66
Natalizumab-associated PML-IRIS: the Chieti experience. 66
JCV-Ab serostatus in MS patients treated with Natalizumab 65
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 65
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 64
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 64
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 64
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 63
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 63
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 57
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 53
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 52
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 48
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 46
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 46
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 43
Totale 3.532
Categoria #
all - tutte 13.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 0 81 59 25 79 68 15
2020/2021283 46 3 59 3 5 52 5 0 41 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025367 50 103 110 11 23 63 7 0 0 0 0 0
Totale 3.532